St. Mary's Medical Center is a regional hospital in Grand Junction, Colorado, in Mesa County. The hospital has 310 beds, making it the largest hospital between Denver and Salt Lake City. The hospital has a Level II trauma center.

There are 310 beds in Saint Mary's Hospital and Regional Medical Center.

During the past decade, Saint Mary's Hospital and Regional Medical Center conducted 81 clinical trials. In the 10-year time frame, 81 clinical trials started and 64 clinical trials were completed, i.e. on average, 79% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 24 clinical trials were completed. i.e. 141.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Mary's Hospital and Regional Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 96 trials, followed by "Radiation Therapy Oncology Group" with 22 trials sponsored, "Alliance for Clinical Trials in Oncology" with 17 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 11 trials sponsored and "SWOG Cancer Research Network" with 11 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Mary's Hospital and Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 68 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Saint Mary's Hospital and Regional Medical Center" are "Head and Neck Cancer" (7 trials), "Invasive Breast Carcinoma" (7 trials), "Recurrent Breast Carcinoma" (7 trials), "Recurrent Melanoma" (6 trials) and "Recurrent Ovarian Carcinoma" (6 trials). Many other conditions were trialed in "Saint Mary's Hospital and Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Saint Mary's Hospital and Regional Medical Center" are "Drug" (149 trials), "Other" (98 trials), "Biological" (86 trials), "Procedure" (48 trials) and "Radiation" (34 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (55 trials), "Quality-of-Life Assessment" (39 trials), "Paclitaxel" (23 trials), "Bevacizumab" (21 trials) and "Questionnaire Administration" (21 trials). Other intervention names were less common.

The vast majority of trials in "Saint Mary's Hospital and Regional Medical Center" are 157 trials for "All" genders, 23 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Mary's Hospital and Regional Medical Center". undefined are not yet recruiting, 30 are recruiting, 80 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 54 completed trials in Saint Mary's Hospital and Regional Medical Center, 4 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Mary's Hospital and Regional Medical Center, 6 "Phase 1" clinical trials were conducted, 73 "Phase 2" clinical trials and 104 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".

Saint Mary's Hospital and Regional Medical Center has several departments that took part in Clinical trials: "St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center" - 94 trials